PL-3994

N/A

Report date: 2024/11/23 20:00:08
NME

Base Information

Drug NamePL-3994
Drug Alias NamePL-3994
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionNatriuretic peptide receptor 1 agonists
TargetsNatriuretic peptide receptor 1
Therapy Area/IndicationsHypertensionHeart Failure, DiastolicAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPalatin Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPalatin Technologies Inc
Active IndicationsN/A
Inactive IndicationsHypertensionHeart Failure, DiastolicAsthma

Other Information

ATC CodeN/A
Related LinksN/A